The editors of a journal that recently retracted a paper after the peer-review process was “compromised” have published the fake reviews, along with additional details about the case.
In the editorial titled “Organised crime against the academic peer review system,” Adam Cohen and other editors at the British Journal of Clinical Pharmacology say they missed “several fairly obvious clues that should have set alarm bells ringing.” For instance, the glowing reviews from supposed high-profile researchers at Ivy League institutions were returned within a few days, were riddled with grammar problems, and the authors had no previous publications.
The case is one of many we’ve recently seen in which papers are pulled due to actions of a third party.
The paper was submitted on August 5, 2015. From the beginning, the timing was suspect, Cohen — the director for the Centre for Human Drug Research in The Netherlands — and his colleagues note: Continue reading Editors say they missed “fairly obvious clues” of third party tampering, publish fake peer reviews
Four different journals have pulled papers from the same authors due to alleged duplication or manipulation of images.
All four papers have two authors in common — Jianting Miao and Wei Zhang, both based at The Fourth Military Medical University in Xi’an City, Shaanxi, China. Many of the other co-authors are also listed in two or three of the retracted papers.
Miao claims that the photographs got “mixed up” due to the researchers’ “great carelessness” and “insufficient knowledge.” He told us:
Continue reading “Mixed up” images earn biologists four retractions
The British Journal of Clinical Pharmacology (BJCP) has retracted a 2015 paper about treating heart failure after deciding its peer review process had been compromised.
This paper is one of the many we’ve noticed lately that have been felled by the actions of a “third party” — in this case, a manuscript editing company called EditPub.
The newly retracted paper, “rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis,” has not yet been cited, according to Thomson Reuters Web of Science.
Here’s the retraction note, which tells us a bit more: Continue reading Pharmacology journal pulls paper because third party “compromised” peer review
Mohammad Reza Safarinejad, a urologist in Iran, has had three papers retracted recently for reasons that are not entirely clear.
Here’s the most recent notice, from the British Journal of Clinical Pharmacology, of a paper that has been cited 23 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Urology researcher in Iran has third paper retracted
The British Journal of Clinical Pharmacology has issued an “expression of concern” for a 2003 review article, based on a previous lecture, with close echoes to a paper that had appeared in one of The Lancet titles.
Here’s the notice for the article, by Peter Winstanley, dean of the Warwick Medical School in the United Kingdom: Continue reading Pharmacology journal expresses concern over “similar, but updated” review